NW-1689 is a process-related impurity of safinamide mesilate (SAFM), which is a medication used in the treatment of Parkinsons disease (PD). SAFM acts as a highly selective and reversible inhibitor of monoamine oxidase-B (MAO-B) and also blocks sodium and N-type calcium channels. These actions assist in reducing dopamine breakdown and suppressing glutamate release. NW-1689 shares structural similarities with SAFM and exhibits comparable pharmacological effects, making it applicable in Parkinsons disease research.
Molecular Weight:
246.23
CAS Number:
[405-85-6]
Formula:
C14H11FO3
Target:
Others
TYD-02772
* VAT and and shipping costs not included. Errors and price changes excepted
